The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB

PLoS Pathogens

Volumn 7, Issue 11, 2011, Pages

  Schneider, Christine L ^a   Hudson, Amy W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; IMMUNOEVASIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICA PROTEIN; MICB PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; IMMUNOMODULATION; LIGAND BINDING; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NATURAL KILLER MEDIATED CYTOXICITY; NONHUMAN; UPREGULATION; VIRUS IMMUNITY;

ANTIGEN PRESENTATION; CARRIER PROTEINS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GPI-LINKED PROTEINS; HEK293 CELLS; HERPESVIRUS 7, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LYSOSOMES; ROSEOLOVIRUS INFECTIONS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 7;

EID: 81755166703     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002362     Document Type: Article

References (50)

1. Tanaka-Taya K, Kondo T, Mukai T, Miyoshi H, Yamamoto Y, et al. (1996) Seroepidemiological study of human herpesvirus-6 and-7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol 48: 88-94.
2. Hansen TH, Bouvier M, (2009) MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 9: 503-513.
3. Powers C, DeFilippis V, Malouli D, Fruh K, (2008) Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325: 333-359.
4. Yewdell JW, Hill AB, (2002) Viral interference with antigen presentation. Nat Immunol 3: 1019-1025.
5. Champsaur M, Lanier LL, (2010) Effect of NKG2D ligand expression on host immune responses. Immunol Rev 235: 267-285.
6. Biassoni R, (2009) Human natural killer receptors, co-receptors, and their ligands. Curr Protoc Immunol Chapter 14: Unit 14.10.
7. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
8. Lanier LL, (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8: 259-268.
9. Lisnić VJ, Krmpotić A, Jonjić S, (2010) Modulation of natural killer cell activity by viruses. Curr Opin Microbiol 13: 530-539.
10. Jonjić S, Babić M, Polić B, Krmpotić A, (2008) Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20: 30-38.
11. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, et al. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
12. Li P, Morris DL, Willcox BE, Steinle A, Spies T, et al. (2001) Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2: 443-451.
13. Li P, Willie ST, Bauer S, Morris DL, Spies T, et al. (1999) Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity 10: 577-584.
14. Radaev S, Rostro B, Brooks AG, Colonna M, Sun PD, (2001) Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15: 1039-1049.
15. Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, et al. (2003) Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 197: 1427-1439.
16. Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, et al. (2003) Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Immunol 170: 4196-4200.
17. Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J, (2009) ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol 39: 3207-3216.
18. Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Soderberg-Naucler C, et al. (2003) Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 171: 902-908.
19. Ashiru O, Bennett NJ, Boyle LH, Thomas M, Trowsdale J, et al. (2009) NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol 83: 12345-12354.
20. Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, et al. (2005) NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201: 211-220.
21. Krmpotić A, Busch DH, Bubić I, Gebhardt F, Hengel H, et al. (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3: 529-535.
22. Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, et al. (2003) NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197: 1245-1253.
23. Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, et al. (2004) The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200: 1075-1081.
24. McSharry BP, Burgert H-G, Owen DP, Stanton RJ, Prod'homme V, et al. (2008) Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J Virol 82: 4585-4594.
25. Thomas M, Boname JM, Field S, Nejentsev S, Salio M, et al. (2008) Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci USA 105: 1656-1661.
26. Thomas M, Wills M, Lehner PJ, (2008) Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus. Biochem Soc Trans 36: 459-463.
27. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O, (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
28. May NA, Glosson NL, Hudson AW, (2010) HHV-7 U21 downregulates classical and non-classical class I MHC molecules from the cell surface. J Virol 84: 3738-3751.
29. Bahram S, Bresnahan M, Geraghty DE, Spies T, (1994) A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 91: 6259-6263.
30. Stephens HA, (2001) MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol 22: 378-385.
31. Glosson NL, Gonyo P, May NA, Schneider CL, Ristow LC, et al. (2010) Insight into the mechanism of human herpesvirus 7 U21-mediated diversion of class I MHC molecules to lysosomes. J Biol Chem 285: 37016-37029.
32. Hudson AW, Howley PM, Ploegh HL, (2001) A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J Virol 75: 12347-12358.
33. Glosson NL, Hudson AW, (2007) Human herpesvirus-6A and-6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 365: 125-135.
34. Groh V, Wu J, Yee C, Spies T, (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
35. Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, et al. (2003) Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102: 1389-1396.
36. Salih HR, Goehlsdorf D, Steinle A, (2006) Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients. Hum Immunol 67: 188-195.
37. Boutet P, Aguera-Gonzalez S, Atkinson S, Pennington CJ, Edwards DR, et al. (2009) Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J Immunol 182: 49-53.
38. Aguera-Gonzalez S, Boutet P, Reyburn HT, Vales-Gomez M, (2009) Brief residence at the plasma membrane of the MHC class I-related chain B is due to clathrin-mediated cholesterol-dependent endocytosis and shedding. J Immunol 182: 4800-4808.
39. Chen X, Trivedi PP, Ge B, Krzewski K, Strominger JL, (2007) Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity. Proc Natl Acad Sci U S A 104: 6329-6334.
40. Krzewski K, Strominger JL, (2008) The killer's kiss: the many functions of NK cell immunological synapses. Curr Opin Cell Biol 20: 597-605.
41. Mistry AR, O'Callaghan CA, (2007) Regulation of ligands for the activating receptor NKG2D. Immunology 121: 439-447.
42. Vales-Gomez M, Winterhalter A, Roda-Navarro P, Zimmermann A, Boyle L, et al. (2006) The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. Cell Microbiol 8: 581-590.
43. Welte SA, Sinzger C, Lutz SZ, Singh-Jasuja H, Sampaio KL, et al. (2003) Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur J Immunol 33: 194-203.
44. Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, et al. (2010) Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328: 102-106.
45. Arapovic J, Lenac T, Antulov R, Polic B, Ruzsics Z, et al. (2009) Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol 83: 8198-8207.
46. Cox JH, Bennink JR, Yewdell JW, (1991) Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J Exp Med 174: 1629-1637.
47. Sester M, Koebernick K, Owen D, Ao M, Bromberg Y, et al. (2010) Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins. J Immunol 184: 255-267.
48. Mostoslavsky G, Fabian AJ, Rooney S, Alt FW, Mulligan RC, (2006) Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci U S A 103: 16406-16411.
49. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, et al. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20.
50. Stam NJ, Spits H, Ploegh HL, (1986) Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137: 2299-2306.